How to buy Amarin Corporation stock | $6.41

Amarin Corporation plc is a biotechnology business based in the US. Amarin Corporation shares (AMRN) are listed on the NASDAQ and all prices are listed in US Dollars. Amarin Corporation employs 1,000 staff and has a trailing 12-month revenue of around 0.00.

Amarin Corporation share price

Use our graph to track the performance of AMRN stocks over time.

Amarin Corporation shares at a glance

• Key figures

Information last updated 2021-05-07.

Latest market close	$6.41
52-week range	$3.36 - $9.25
50-day moving average	$5.58
200-day moving average	$5.74
Wall St. target price	$10.25
PE ratio	2269.9998
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.00

Buy Amarin Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Amarin Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Amarin Corporation plc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amarin Corporation price performance over time

Historical closes compared with the close of $6.41 from 2021-03-11

1 week (2021-05-06)	41.19%
1 month (2021-04-13)	26.18%
3 months (2021-02-12)	-18.03%
6 months (2020-11-13)	49.77%

1 year (2020-05-13)	-13.61%
2 years (2019-05-13)	-60.60%
3 years (2018-05-11)	103.49%
5 years (2016-05-13)	298.14%

Is Amarin Corporation under- or over-valued?

Valuing Amarin Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amarin Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amarin Corporation's P/E ratio

Amarin Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2270x. In other words, Amarin Corporation shares trade at around 2270x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Amarin Corporation's EBITDA

Amarin Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.1 million.

The EBITDA is a measure of a Amarin Corporation's overall financial performance and is widely used to measure a its profitability.

Amarin Corporation financials

Revenue TTM	$601.2 million
Operating margin TTM	0.51%
Gross profit TTM	$482.6 million
Return on assets TTM	0.2%
Return on equity TTM	0.15%
Profit margin	0.15%
Book value	$1.61
Market capitalisation	$1.8 billion

TTM: trailing 12 months

Shorting Amarin Corporation shares

There are currently 26.0 million Amarin Corporation shares held short by investors – that's known as Amarin Corporation's "short interest". This figure is 16.7% up from 22.3 million last month.

There are a few different ways that this level of interest in shorting Amarin Corporation shares can be evaluated.

Amarin Corporation's "short interest ratio" (SIR)

Amarin Corporation's "short interest ratio" (SIR) is the quantity of Amarin Corporation shares currently shorted divided by the average quantity of Amarin Corporation shares traded daily (recently around 5.7 million). Amarin Corporation's SIR currently stands at 4.58. In other words for every 100,000 Amarin Corporation shares traded daily on the market, roughly 4580 shares are currently held short.

However Amarin Corporation's short interest can also be evaluated against the total number of Amarin Corporation shares, or, against the total number of tradable Amarin Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amarin Corporation's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Amarin Corporation shares in existence, roughly 70 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Amarin Corporation shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Amarin Corporation.

Find out more about how you can short Amarin Corporation stock.

Amarin Corporation share dividends

We're not expecting Amarin Corporation to pay a dividend over the next 12 months.

Have Amarin Corporation's shares ever split?

Amarin Corporation's shares were split on a 1:10 basis on 17 January 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amarin Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amarin Corporation shares which in turn could have impacted Amarin Corporation's share price.

Amarin Corporation share price volatility

Over the last 12 months, Amarin Corporation's shares have ranged in value from as little as $3.36 up to $9.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Amarin Corporation's is 2.2433. This would suggest that Amarin Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Amarin Corporation overview

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co. , Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999.

Frequently asked questions

• What percentage of Amarin Corporation is owned by insiders or institutions?

  Currently 1.18% of Amarin Corporation shares are held by insiders and 38.981% by institutions.

• How many people work for Amarin Corporation?

  Latest data suggests 1,000 work at Amarin Corporation.

• When does the fiscal year end for Amarin Corporation?

  Amarin Corporation's fiscal year ends in December.

• Where is Amarin Corporation based?

  Amarin Corporation's address is: Grand Canal Docklands, Dublin, Ireland, 2

• What is Amarin Corporation's ISIN number?

  Amarin Corporation's international securities identification number is: US0231112063

• What is Amarin Corporation's CUSIP number?

  Amarin Corporation's Committee on Uniform Securities Identification Procedures number is: 023111107